<ul><li>Wobble Genomics secures £21.8M Series A funding for its groundbreaking RNA sequencing technology.</li><li>The funding round, led by Mercia Ventures and BGF, reflects investor confidence in Wobble Genomics' vision.</li><li>Wobble Genomics aims to unlock the full potential of RNA sequencing and provide deeper insights into cellular mechanisms and biotechnology.</li><li>The company's unique approach allows for long-read sequencing, overcoming challenges in detecting 'full length' RNA molecules.</li></ul>

Mission Zero Technologies Secures £21.8M Series A Funding for Groundbreaking DAC Solutions

Discover more